spacer
home > pmps > winter 2002 > packaging - the future in 3d
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Packaging - The Future in 3D

So - you are a drug company, you have a new chemical entity (NCE) that has taken you eight years to develop. You have run probe studies and the product works (12 months) and a market container study. With all the paperwork to file the drug and get launch approval, the process took a further two years.

Along the way marketing have selected the shape and look they want and identified the launch market. Sales have geared up to sell the product and your affiliates are readying production at five primary and five back-up sites. Already your global procurement is ready to start to reduce the COPS, and the formulation has been passed on for product line extension development.

Packaging technology groups are looking at cost optimisation. The FDA/MCA are watching every step to make sure everything is as it should be. If your drug is a blockbuster then Wall Street and the City, along with your shareholders, have been watching you for the last three years - and anything other than an on-time launch, scale-up and market penetration is a failure for all the scientists, marketers, sales teams and purchasing professionals in the business. Worried?


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Nic Hunt, Global Business Director for Rexam Pharma Flexibles and Rexam Pharma Services
Nic Hunt has worked globally in medical, pharmaceutical and personal care packaging for 15 years in research, process development, product development, marketing and business management.

He is currently the Global Business Director for Rexam Pharma Flexibles and Rexam Pharma Services - focusing on developing new barrier systems and packaging solutions for the pharmaceutical industry.

spacer
Nic Hunt
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Clinical Trial Supply West Coast Conference 2019

Philadelphia, USA – April 24, 2019. This year’s Clinical Trial Supply West Coast Conference will see leading biopharmaceutical outsourcing services provider PCI Pharma Services (PCI) showcasing its specialist clinical trials expertise in relation to scheduled drugs.
More info >>

White Papers

Time lapse photography to demonstrate the potential antimicrobial abilities of Dycem contamination control flooring

Dycem

A defined volume of bioluminescent reporter bacteria was deposited onto 20 mm x 20 mm coupons of Dycem flooring, vinyl tile and ITW Alma tacky mat. Through monitoring of bacterial bioluminescence, metabolic inhibition was observed on all three surfaces however the effect occurred more rapidly on Dycem flooring than on vinyl or ITW Alma. Recovery counts after three hours of exposure to the floor surfaces showed between a 65% and 100% decrease in the number of viable organisms recovered from Dycem flooring compared to controls. On vinyl and ITW Alma flooring, there were slight increases in the number of viable survivors recovered compared to controls. Dycem flooring inhibited the metabolic activity and reduced the number of viable survivors recovered of Salmonella enterica Serovar Typhimurium DT104 pGLITE. It remains unclear as to whether this effect is attributable to the impregnated biocide or rapid drying of the inoculum on this surface.
More info >>

 
Industry Events

Multimodal 2019

18-20 June 2019, NEC, Birmingham, UK

Now in its twelfth year, Multimodal is the UK and Ireland’s premier freight transport, logistics and supply chain management event.  Shippers and cargo owners attend to improve their businesses; by finding ways of moving their products more efficiently and by meeting new suppliers. 
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement